S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer

Clinical trial NCT00068783 · COMPLETED

Trial details

NCT number: NCT00068783
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Neuroendocrine Carcinoma of the Skin Stage II Neuroendocrine Carcinoma of the Skin Stage III Neuroendocrine Carcinoma of the Skin

Start date: 2003-10-01
Primary completion: 2007-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.